Hull H F
Minnesota Department of Health, Minneapolis 55414, USA.
Lancet Infect Dis. 2001 Dec;1(5):299-303. doi: 10.1016/S1473-3099(01)00143-8.
As the global polio eradication initiative comes ever closer to its goal of terminating of all wild poliovirus transmission, significant challenges remain. Wild poliovirus transmission must be terminated in countries where low-level transmission persists, in large reservoir countries with high population density, and in conflict countries. Eradication can be achieved in these countries with determined and persistent effort, assuming that sufficient resources are mobilised. High quality surveillance needs to be implemented in the remaining polio endemic countries, especially in Africa. Surveillance is necessary in all countries until eradication is certified. A strategy for stopping immunisation after eradication is yet to be defined. A definition of this strategy would address the emergence of feral polioviruses, chronic vaccine virus infection in immunodeficient persons, and containment of laboratory strains. Until immunisation is stopped, high-population immunity should be maintained through uniformly high immunisation coverage with potent vaccines.
随着全球根除脊髓灰质炎行动日益接近终止所有野生脊髓灰质炎病毒传播的目标,重大挑战依然存在。在仍存在低水平传播的国家、人口密度高的大型病毒储存国以及冲突国家,必须终止野生脊髓灰质炎病毒的传播。只要调动足够资源,通过坚定和持续的努力,这些国家就能实现根除目标。在其余脊髓灰质炎流行国家,尤其是非洲国家,需要实施高质量监测。在所有国家都有必要进行监测,直至根除得到认证。根除后停止免疫的策略尚未确定。这一策略的定义将涉及野生脊髓灰质炎病毒的出现、免疫缺陷者的慢性疫苗病毒感染以及实验室毒株的控制。在停止免疫之前,应通过使用高效疫苗实现统一的高免疫覆盖率,以维持高人群免疫力。